MedMira Inc (MIR : TSX-V)
Common Stock
$0.07
CAD
+0.00 (%)
Last updated: 2026-10-13
Follow MIR
MIR
MedMira Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+8.33%
1 Month
-7.14%
YTD
+0.00%
Key Statistics
Market Cap
$45.61M
52W High
$0.10
52W Low
$0.05
P/E Ratio
-
50 Day MA
$0.07
200 Day MA
$0.07
Beta
0.78
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/13/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 11,000 |
| 10/8/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 95,000 |
| 10/6/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 0 |
| 10/2/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 0 |
| 10/1/2026 | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 | 16,049 |
| 9/28/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 20,100 |
| 9/25/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 183,335 |
| 9/23/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 1,000 |
| 9/22/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 40,000 |
| 9/21/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 1,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIR's historical volatility
30-Day Vol
110.3%
Annualized
90-Day Vol
100.5%
Annualized
Trend (90d)
-31.1%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.09 |
| 60 trading days | C$0.06 | C$0.04 – C$0.10 |
| 90 trading days | C$0.06 | C$0.03 – C$0.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Financials
- Revenue (TTM)
- $370,568
- EBITDA
- $-1.94M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- 0.00
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MIR
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RSC-P | Rockmount Capital Corporation | $0.12 | +380.00% |
| CTA | Centaurus Energy Inc | $5.08 | +138.50% |
| PUL | Pulse Oil Corp | $0.01 | +50.00% |
| EVNT | Eventer Technologies Ltd. | $1.50 | +41.51% |
| VIS | Visionstate Corp | $0.02 | +33.33% |
| NCI | NTG Clarity Networks Inc. | $0.42 | +33.33% |
| MAPS | Prostar Holdings Inc | $0.18 | +28.57% |
| OTMC | Oreterra Metals Corp. | $0.45 | +27.14% |
MIR.V news timeline
15 articles covering MIR.V, most recent first
Latest